Skip to main content
NUMD logo

NUMD · Nu-Med Plus, Inc.

Track NUMD — free
$0.02 0.00 (-5.74%) At close · Aug 28
Market Cap
$1.92M
Shares
83.55M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.02 Open$0.02 Day$0.02–0.02 52W close$0.01–0.05 Avg vol 30d53K Short int36K · 0.0% float · 87.9d Short vol40% DataJan 2020–Aug 2026 Filing10-Q · Aug 14

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Aug 14, 2026

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Neutral Momentum Neutral Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 14.9 · calm Equity put/call 0.70
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −37%
below
Price vs 50-day avg +31%
above
RSI (14) 58
neutral
MACD trend Positive
52-week position 38%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Neutral
1-month return +142%
trailing
6-month return −74%
trailing
YTD return +33%
this year
Relative strength −88%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
0.04% of float · ▬ 0.0% MoM · 87.9 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Steady
No 13F holder history
Squeeze score 45
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 806%
annualized · 1-yr
Max drawdown −92%
past year
ATR 9.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
1 · 4 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−37% Bearish
Price vs 50-day avg
+31% Bullish
RSI (14)
58 Neutral
MACD trend
Positive Bullish
52-week position
38% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
No clear signal
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
0.04% of float · ▬ 0.0% MoM · 87.9 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0 Now $0 · 38% Range high $0
vs 200-day avg -37% vs 50-day avg +31%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
NUMD
Nu-Med Plus, Inc.
this stock
$1.92M +32.9% 0.0%
ABT
Abbott Laboratories
$191.81B -11.9% +5.7% 30.9 1.2%
SYK
Stryker Corp
$126.84B -7.9% +11.2% 34.3 1.8%
MDT
Medtronic plc
$116.78B -5.6% +8.4% 24.5 1.1%
BSX
Boston Scientific Corp
$70.00B -49.3% +12.5% 19.6 1.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest
Shares short
35.7K
Days to cover
87.9d
Change
0 sh
View
Short Volume
Short vol %
40%
As of
Aug 28, 2026
Short Total
View
Fails to Deliver
FTD shares
4.5K
Value
$45
As of
Apr 28, 2026
View
Off-Exchange
Off-exchange %
100.0%
Week of
Jul 20, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$0
Net income (FY)
$-56.2K
EPS diluted
$0.00
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 25, 2026
This year
6
View

Performance

5D 20D 120D MTD YTD
NUMD -5.4% +142.1% -74.4% +25.0% +33.0%
SPY +0.5% +3.0% +13.4% +3.0% +12.8%
vs SPY -5.8% +139.1% -87.9% +22.0% +20.1%
Key facts CIK 1543637 CUSIP 67021R104 13F (30d) 1 filings 1 filers